Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion type Assertion NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_head.
- NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion description "[We have evaluated the effects of doses ranging from 10 ng to 100 micro g of two CC chemokine receptor antagonists, Met-RANTES/CC chemokine ligand 5 (CCL5) and aminooxypentane-RANTES/CCL5, in preventing inflammation in the OVA-sensitized murine model of human asthma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_provenance.
- NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion evidence source_evidence_literature NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_provenance.
- NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion SIO_000772 14607956 NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_provenance.
- NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion wasDerivedFrom befree-2016 NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_provenance.
- NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_assertion wasGeneratedBy ECO_0000203 NP419964.RAfzmSopHmpdtXKXi7KcOgnN3bnItzvFRKcLXDEPuJbcI130_provenance.